Vulnerabilities

Vulnerability · CVE-2026-111128

Assimp through 6.0.5 contains a NULL pointer dereference vulnerability in the Ogre3D importer that allows attackers to crash applications via unvalidated bone indices…

Published Oct 15, 2026 · catalog updated Oct 16, 2026 · the affected product

Check if you run it

No confirmed exploitation is on record for CVE-2026-111128. EPSS is 0.20%. Act only if a listed version of the affected product is installed.

Gaps on this record

  • No plain product name is stored. The page cannot tell you which product to check.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium6.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.20%
Remediation
Advisory link
Affected products
Debian:12 assimp · Debian:13 assimp · Debian:14 assimp

Assimp through 6.0.5 contains a NULL pointer dereference vulnerability in the Ogre3D importer that allows attackers to crash applications via unvalidated bone indices in OgreStructs.cpp. Attackers can supply a crafted .mesh and .skeleton file referencing a missing bone, causing BoneById() to return null and crash the host process.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • Debian:12 assimp5.2.5~ds0-1, 5.2.5~ds0-1.1, 5.3.1+ds-1
  • Debian:13 assimp5.4.3+ds-2, 5.4.3+ds-3, 6.0.2+ds-1
  • Debian:14 assimp5.4.3+ds-2, 5.4.3+ds-3, 6.0.2+ds-1

How to fix CVE-2026-111128

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-111128. EPSS is 0.20%. Act only if a listed version of the affected product is installed.

Which versions are affected?

Compare what you have installed with 5.2.5~ds0-1, 5.2.5~ds0-1.1, 5.3.1+ds-1, 5.4.3+ds-2, 5.4.3+ds-3, 6.0.2+ds-1. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-476: NULL Pointer Dereference. EPSS 0.20%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Technology hubs

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Oct 15, 2026 · NIST NVD

    Detected

    Assimp through 6.0.5 contains a NULL pointer dereference vulnerability in the Ogre3D importer that allows attackers to crash applications via unvalidated bone indices in OgreStructs.cpp. Attackers can supply a crafted .mesh and .skeleton file referencing a missing bone, causing BoneById() to return null and crash the host process.

  2. Oct 16, 2026 · OpenSSF OSV / OSV Scanner

    Updated

    Assimp through 6.0.5 contains a NULL pointer dereference vulnerability in the Ogre3D importer that allows attackers to crash applications via unvalidated bone indices in OgreStructs.cpp. Attackers can supply a crafted .mesh and .skeleton file referencing a missing bone, causing BoneById() to return null and crash the host process.

Sources

  • CVE.orgVulnerability recordCVE-2026-111128

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-111128

    30-day exploitation probability 0.2%

    first.org
  • NIST NVDVulnerability recordCVE-2026-111128

    Assimp through 6.0.5 contains a NULL pointer dereference vulnerability in the Ogre3D importer that allows attackers to crash applications via unvalidated bone indices in OgreStructs.cpp. Attackers can supply a crafted .mesh and .skeleton file referencing a missing bone, causing B

    nvd.nist.gov
  • OpenSSF OSV / OSV ScannerPackage advisoryDEBIAN-CVE-2026-111128
    osv.dev

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.